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Abstract 
Background: Endovascular abdominal aortic aneurysm repair (EV AR), when 
compared to conventional open surgical repair, has been shown to reduce 
perioperative morbidity and mortality. A retrospective cohort study was 
performed with data from the Department of Veterans Affairs to examine 
outcomes in routine daily practice following EV AR and open surgical repair. 
Methods: In this study, I examined 30-daymortality, !-year survival, and 
postoperative complications in 1957 patients who underwent elective AAA repair 
(EV AR n=717 (36.6%); open n=l240 (63.4%)) at 123 VA hospitals between May 
I, 2001 and September 30, 2003. Also, this review investigated the influence of 
patient, operative, and hospital variables on outcome, and used propensity scoring 
to adjust for the nonrandom allocation of patients to either EV AR or open J l 
procedures. 
Results: Patients undergoing EV AR had significantly lower 30 day (3.1% vs. 
5.7%, p=0.0079) and I year mortality (8.4% vs. 12.0%, p=O.Ol21) than patients 
having open repair. EV AR was positively and independently associated with a 
decrease in 30-day postoperative mortality (adjusted OR=0.58; 95% CI=0.35, 
0.97; p=0.0367). The risk of any perioperative complication was much less 
following EV AR (4.5% vs. 14.2%; p<O.OOOl; unadjusted OR 0.48; 95% CI 
=0.37, 0.63; p<O.OOI). Patients operated on at low volume hospitals (25% of ; +--
entire cohort) were more likely to have had open repair (31.6% compared to 
15.9% EV AR; p <0.001) as well as a two-fold increased adjusted 30-day 
mortality risk (OR=2.06; 95% CI=l.32, 3.26; p=0.0015). 
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Conclusions: In routine daily practice, patients presenting for elective AAA repair 
who undergo EV AR have substantially lower perioperative mortality and 
morbidity rates compared to patients having open repair. The benefits of a 
minimally invasive approach were readily apparent in this cohort; however, 
caution should be exercised in choosing EV AR for all elective AAA repairs until 
longer-term data on device durability are available. Furthermore, widely available 
screening programs may aid in the early detection of AAA, which would further 
facilitate timely surgical intervention and, ultimately, improve outcomes. 
L 
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Introduction 
The goal of elective repair of abdominal aortic aneurysms (AAA) is to 
improve longevity by preventing aneurysm rupture and subsequent death. The 
introduction of endovascular grafting, the treatment of an AAA by inserting an 
endovascular graft retrograde through an open femoral artery into the abdominal 
aorta, by Juan Parodi in 1991, was a milestone in the management of patients with 
AAA. 1 This technical advance has been embraced with enthusiasm because of the 
potential for reducing perioperative morbidity and mortality, and recovery time, 
especially in patients deemed at high surgical risk by conventional open 
standards? However, defining an appropriate strategy for choosing either 
conventional open or endovascular repair remains a complex clinical endeavor. 
Even minimally invasive interventions may be associated with adverse early 
outcomes, and the presumption that an endovascular approach confers less risk for 
perioperative mortality compared with the results of standard open surgery in 
patients at low risk remains unproven. 
Single institution series or clinical experiences from controlled industry-
sponsored trials have populated the literature, with illustrative data showing a 
positive impact on mortality rate following intact infrarenal AAA repair3 -7 In a 
meta-analysis published in 2002, the results of9 studies involving 1,318 
procedures (687 EV AR and 631 open surgical repair) was reported, with an 
aggregate 30-day mortality rate of3% for EV AR and 4% for open repair 
(p=0.03).8 Additionally, in 2004, short-term data (30-day) from the first 2 
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randomized trials comparing elective EV AR to open repair have demonstrated 
superiority ofEV AR in reducing perioperative mortality.9•10 
The main purpose of this study was to compare postoperative mortality 
and complications and 1 year survival in patients undergoing elective EV AR 
versus open repair within a national publicly funded health care system. 
Secondarily, I will discuss the importance of screening programs to improve and 
expedite the diagnosis, and ultimately, quality of delivered care to patients with 
AAAs. 
Methods 
Data Sources and Sample 
All patients who underwent either EV AR or open abdominal aortic 
aneurysm repair between May 1, 2001 and September 30, 2003 were identified 
through the Veterans Health Administration's (VA) National Surgical Quality 
Improvement Program (NSQIP) database11 of surgical procedures performed at 
123 participating VA hospitals. This time frame was chosen because prior to May 
2001, no suitable current procedural terminology (CPT) codes existed in the 
database for EV AR, though endovascular grafting systems were approved by the 
US Food and Drug Administration and became commercially available in 
September 1999. Patients undergoing elective repair were defined by primary 
diagnostic code (ICD-9-CM 441.4: intact, non-ruptured AAA); open AAA repairs 
were defined by CPT codes 35081, 34830, 34831, and 34832. The last 3 codes 
represent elective open repair after EV AR; thus, a non-urgent operation with 
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similar risks of primary open repair (data analysis was not performed in an intent-
to-treat manner). EV AR was defined by codes 34800, 34802, and 34804. Patients 
with secondary diagnostic codes for ruptured AAA or thoracic or 
thoracoabdominal aortic aneurysm were excluded from the analysis. 
The NSQIP database contains very detailed, prospectively collected 
clinical data on all patients undergoing major surgical procedures within the 
V A. 11 At the time of surgery, patients are enrolled in NSQIP, and baseline 
demographic, pre-operative laboratory and clinical information is collected by 
dedicated trained nurse reviewers. Additional perioperative data are prospectively 
collected by the nurses, including 30-day morbidity and mortality information. 
From the NSQIP database we identified 1973 elective repairs of non-ruptured 
aneurysms, which occurred between May 2001 and September 2003. Of these, 9 
records were found to represent a second operation on the same individual; these 
9 records were excluded from analysis. 
To supplement the information in the NSQIP records with longer-term 
utilization and vital statistics data, encrypted social security numbers, date of 
admission, date of discharge, and primary operative date were used to link the 
NSQIP database with the VA Patient Treatment File (PTF), which contains 
abstracts of all patients discharged from all VA hospitals. Seven patients (0.36%) 
for whom a match could not be made were excluded from further study. Thus, 
1957 unique patients were included in for analysis. A total of 717 EV AR and 
1240 open cases formed the basis of this study. Of the 1240 open cases, 53 (4.3%) 
patients had elective open repairs following EV AR. To obtain additional 
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information, linkages were performed with the VA Outpatient Clinic File (OPC), 
which contains records for every outpatient visit to a VA facility, and the VA 
Beneficiary Identification Record Locator System (BIRLS) death file. Approval 
for the study was obtained from the Baylor College of Medicine Institutional 
Review Board and the Michael E. DeBakey VA Medical Center Research and 
Development Review Committee as well as the University of North Carolina 
School of Public Health Institutional Review Board. 
Definition of independent variables 
Patient demographic data are recorded prospectively in the NSQIP 
database including age, gender, race, and hospital location. Comorbid conditions 
known to have an influence on the risk of cardiovascular morbidity and mortality 
were chosen for analysis.2' 12•13 These independent variables were defined using 
NSQIP definitions and the International classification of diseases, ninth revision, 
Clinical modification (ICD-9-CM) codes. Within NSQIP, nurse reviewers 
recorded diabetes (persons using insulin or oral hypoglycemic agent), renal 
dysfunction or dialysis dependence, hepatic dysfunction, history of malignancy, 
history of congestive heart failure during the month preceding surgery, history of 
stoke or transient ischemic attacks, functional status, and tobacco use within the 
year preceding AAA repair. Additionally, 24 individual comorbid conditions were 
identified in the PTF and the analysis also included a separate variable for 
elevated creatinine(?. 2.0 mg/dL) which was based on the Revised Cardiac Risk 
Index. 13 American Society of Anesthesiology (ASA) classification. Both the 
L 
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inpatient and outpatient files were searched for matching ICD-9-CM codes I year 
prior to the operation date in order to have complete patient comorbidity profiles. 
Baseline characteristics of patients are given in Table I. EV AR patients 
consisted of a significantly older population with progressively increasing 
percentages of patients having EV AR compared to open repair in the older age 
categories. Younger patients were more likely to have open repair. Patients 
undergoing EV AR were significantly less likely than patients having open repair 
to have a history of cerebrovascular disease, to have smoked within the year prior 
to AAA repair, to have a carotid lesion, and to have been operated on at low 
volume hospitals and more likely to have had cirrhosis. Overall, the two cohorts 
were remarkably similar given the retrospective nature of the analysis. 
Outcome Measures 
The outcomes of interest included 30-day and I year mortality, and any 
postoperative complications. Thirty-day mortality was obtained from the NSQIP 
database; !-year mortality was calculated using death dates obtained from BIRLS 
and the PTF. Perioperative complications from the NSQIP were aggregated into 
categories including adverse cardiac events, renal dysfunction, pulmonary 
complications, wound complications, neurological complications, and graft 
failure. Unfortunately, there is no strict definition in the NSQIP for what 
constitutes a "graft failure", thus, this variable may be misleading and difficult to 
make conclusions from. Postoperative length of stay and ICU length of stay were 
calculated using the date of surgical repair as the index date. 
Hospital Volume 
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While a direct correlation between high volume hospitals and better 
outcomes for open elective AAA repair has been well documented in the 
literature, no study has assessed the significance of the volume effect for 
endovascular repair. 14-16 Because of potential confounding due to the volume of 
operations performed at each site, we created an indicator variable for low 
volume, for all patients who had their surgery at a hospital which performed fewer 
than 10 procedures (EV AR or open) per year. 15 Patients operated on from May 
2001 through September 2001 were classified as being at low volume sites if 
those sites performed fewer than 4 operations during this abbreviated time period. 
Statistical Analysis 
Bivariate tests of association with type of surgery were performed for all 
demographic and clinical characteristics by the use of chi-square tests for 
categorical variables and t-tests for continuous variables (age). All clinical 
outcomes of interest were similarly tested for association with type of surgery 
performed. All independent measures and type of surgery were then tested for 
their unique association with the morbidity and mortality outcomes (30-day and 
365-day) in multi variable logistic regression models with a significance level of 
0.10 required to stay in the final model. This level was selected arbitrarily to 
capture as many possible confounding factors as might be strongly associated 
with both the selection ofEV AR and postoperative outcomes. Age was tested for 
linear association and found to have the best empirical fit as a categorical variable 
(greater than or equal to 80 years). An interaction term oflow volume with type 
of surgery was not statistically significant. Models were assessed for goodness of 
fit by the Hosmer-Lemeshow statistic and for discrimination by the c-index.17-19 
Further testing of time to death was done with Kaplan-Meier curves evaluated 
with the log-rank test. 
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Propensity scoring was used to try to minimize the selection bias inherent 
in this nomandomized observational study. The predicted probability of receiving 
EV AR was tabulated for all patients, based on a multiple logistic regression of all 
independent demographic and clinical characteristics, and stratified into 5 groups. 
Patients were thus matched within strata based on similar levels of the 
independent measures, creating a pseudo-randomized control design.20 The 
proportion of patients with the morbidity and mortality outcomes was then 
compared between the EV AR and open procedures between strata. 
All analyses were performed using SAS Unix version 9.0. All other 
significance tests were conducted at an alpha level= 0.05. 
Results 
Patients undergoing EV AR had statistically significantly better outcomes-
lower short and long-term mortality rates, lower complication rates, and shorter 
hospital and ICU length of stays- than patients undergoing traditional open 
aneurysm repair (Table 2). 
Mortality 
Patients undergoing EV AR had a lower risk of postoperative mortality 
than those having open repair (Table 3). The adjusted odds ratio (95% CI and p-
value) of EV AR for 30-day mortality, after controlling for statistically significant 
I 
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independent risk factors, was 0.58 (0.35, 0.97; p=0.0367). One-year survival was 
also significantly better in the EV AR cohort with an adjusted OR of 0.59 (0.42, 
0.84; p=0.0028). Patients operated on at low volume hospitals, regardless of 
surgery type, had a more than two-fold increase in risk (OR=2.06, CI 1.32,2.30, 
p=0.0015) for 30-day mortality. Patients at low volume sites were also at 
increased risk for one-year mortality, albeit not statistically significant (OR 1.35, 
CI 0.97, 1.88, p=0.078). Kaplan-Meier analysis (Figures La and l.b) further 
demonstrated significant differences in both 30-day (p=0.0058) and 1 year 
(p=O.Ol04) survival rates. Furthermore, after stratifying the patients by their 
propensity to undergo EV AR or open surgery, the proportion of patients with 
deaths within one year were higher among patients receiving open repair in all 
groups substantiating our results (Figure 2). 
Postoperative complications 
Patients undergoing EV AR had a significantly lower overall adjusted rate 
of postoperative complications (OR 0.48; 95% CI 0.37, 0.63; p<O.OOOl). In 
bivariate analysis, cardiac and pulmonary complications as well as graft failure 
reached statistical significance (Table 4). There were 3 instances of complete graft 
failure in which the endovascular graft was removed and traditional open repair 
completed. Two of these cases occurred within 30 days ofEV AR and one case 
was 5 months post-implantation. After controlling for type of surgery, 
independent predictors for an increased risk of mortality and complications in 
risk-adjusted models were hepatic comorbidity, cancer diagnosis, arrhythmias, 
renal insufficiency, ASA class 4 or 5, transient ischemic attack, history of COPD, 
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history of CHF, hypertensive renal function, cirrhosis, angina, and carotid disease. 
There was no difference in complication rates between lower and higher volume 
hospitals (p=O.I6). 
Length of stay 
Patients having EV AR utilized significantly fewer hospital days than those 
having open repair. The median ICU length of stay for EV AR was I day 
(interquartile range I, 2 days) and for open repair was 4 days (interquartile range 
2, 6 days). Total postoperative length of stay was also shorter following EV AR 
than open repair (EV AR: median 3, interquartile range 2, 5 days; open: median 7, 
interquartile range 6, II days). t 
Figure 2 presents the outcomes of patients matched on propensity to 
! ; Propensity score analysis 
undergo EV AR surgery, stratified by the probability of undergoing EV AR vs. 
open repair. Patients in the middle group were equally likely to have open or 
EV AR repair, based on their presenting demographic and clinical characteristics. 
Patients in the left-most group on the chart were most likely to have open, 
whereas patients in the right-most group were most likely to have EV AR. The 
proportion of patients with 30-day death was higher for those patients having 
open repair, in all sub-groups except moderate-probability EV AR. The proportion 
of patients with deaths within one year were higher among patients receiving open 
repair in all groups, and the proportion of patients with occurrence of any 
complication were higher among patients receiving open repair in all groups 
except those equally likely to have either operation. The proportions of patients 
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experiencing these morbidity and mortality outcomes generally decreased as the 
probability ofEV AR increased. Conversely, the proportion of patients operated 
on at low volume hospitals increased dramatically as the probability of open 
repair increased (88.2%), where patients also had the highest proportions of these 
adverse outcomes. 
Discussion 
In this cohort of patients, representing routine surgical practice, patients 
presenting for elective AAA repair who underwent EV AR had statistically 
significantly lower risk-adjusted perioperative and 1-year mortality, lower 
complication rates, and shorter lengths of stay compared to patients having open 
repair. The sample was restricted by querying the database for only those cases 
performed after the introduction of endovascular CPT codes in May 2001. These 
findings with regard to outcomes following EV AR and open AAA repair are 
consistent with several other published studies including those using national 
administrative databases, with additionall-year survival via database linkage. 
All of the perioperative outcomes analyzed, including 30 day and 1-year 
mortality rates, postoperative complications, and length of stay, favored 
endovascular repair in this veteran population. Patients undergoing open AAA 
repair were found to be younger and had a higher prevalence of cerebrovascular 
disease and carotid lesions, and lower prevalence of cirrhosis than those 
undergoing EV AR. Open patients were also more likely to have smoked within 
the year preceding repair. Otherwise, the 2 cohorts were well matched in terms of 
preoperative comorbid conditions including ischemic heart disease, history of 
myocardial infarction, pulmonary and renal function, all of which are known to 
influence postoperative outcomes after elective AAA repair21 
There are several competing explanations for the results of our analyses. 
14 
The foremost reason is that EV AR is simply a superior treatment modality for 
elective aortic aneurysm repair. Studies have been performed measuring changes 
in physiologic response via plasma catecholamine concentrations, changes in 
cardiovascular variables, and acid-base status in patients undergoing either 
elective EV AR or open repair.22-24 The less invasive endoluminal operation 
results in a lowering of the hypermetabolic stress response. Additionally, 
significant changes have been documented in various cardiovascular parameters 
including cardiac output, mean arterial pressure, and systemic vascular resistance 
during open repair related to aortic cross-clamping.Z4 Acute aortic occlusion 
(cross-clamping) and the subsequent reperfusion of the lower extremities are 
necessary maneuvers during open repair that may result in varying degrees of 
hemodynamic instability in a patient population intrinsically at high risk for 
cardiovascular disease. 
An additional explanation for our findings is selection bias for patients to 
have either type of repair depending on the treating facility and the access to 
endovascular repair. EV AR is a technically demanding procedure not extensively 
taught in vascular surgical training programs until recent years, so it may not be 
offered at every hospital. Our propensity scoring demonstrated that EV AR tended 
to have lower 30-day and 1-year mortality compared to open repair in almost all 
propensity score subgroups. 
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In subset analysis, it was found that 25% of all patients had been treated at 
low volume hospitals (those performing <10 AAA repairs per year) and 41% of 
these patients died within 30 days of their operation. It has been suggested that 
veteran patients may have more comorbidities and a greater severity of illness 
than non-VA sector patients25•26 , thus, one may expect worse results following 
specific surgical procedures such as open AAA repair, especially in lower volume 
institutions. Therefore, the non-VA population may have even better outcomes 
than seen in this NSQIP study. Specific reasons for this are not available in this 
dataset. On the other hand, there is evidence for better outcomes following 
elective open repair of smaller aneurysms in fit patients.27•28 However, aneurysm 
size is not currently recorded in the existing VA database. 
Many believe the question of which operation to perform for elective 
AAA repair would best be answered by a prospective multicenter randomized 
trial. Such a trial (VA Cooperative Trial #498) is currently underway in the VA 
health system and will span 5-7 years involving 39 centers. However, the results 
of recent randomized trials ofEV AR versus open repair demonstrate a 30-day 
mortality advantage for EV AR patients; long term data are not yet available.9'10 A 
factor in interpreting results of the recently published trials, is that to be 
considered a candidate for randomization, a patient has to be eligible for either 
operation. The suitability for EV AR is reported to range from only 20% to 60% 
depending on anatomical criteria or device availability29.31 This data set used 
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herein may represent more accurately the spectrum of medical care than the 
setting of a randomized experiment. Furthermore, generalizability of the results of 
a prospective randomized trial to everyday common surgical practice may not be 
possible. 
Using this prospectively collected observational data combined with 
administrative data, a propensity score approach was employed to replicate 
randomization. By using this statistical modality that grouped patients with 
similar risk profiles on the basis of their propensity to undergo either open AAA 
repair or EV AR, a comparison was performed for 30-day operative mortality 
between those who actually had open AAA repair or EV AR. After the patients 
were matched by propensity to undergo a certain type of operation, differences 
between the two groups became apparent, with higher mortality rates in those 
having had open AAA repair irrespective of the propensity score to undergo open 
repair. These findings differ from others and are more reliable in that all 
confounding background variables have been reduced into one single composite 
characteristic. By performing subclassification, simultaneously adjustment for 
many co variates is accomplished which allows for a reliable estimation of the 
effects of open repair versus EV AR. Other large-scale database analyses have 
relied on standard regression-based risk adjustment techniques, which are limited 
in their inability to assure balance in the distributions of covariates between types 
of operation performed. 
Multiple authors have discussed the relationship between hospital volume 
and risk-adjusted outcome for AAA repair. 14•16•32•33 Varying definitions for what 
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constitutes a low-volume center have been suggested based on post-hoc analyses. 
A recent systematic review of 15 studies published from 1980 to 1997 on 
outcome related to hospital volume reported the number of median cases per year 
defining a low volume hospital as 10 (range 5 to 50)15 To assess whether these 
findings concerning lower volume centers may have biased our mortality findings 
in favor of higher volume hospitals, the adjusted one-year mortality rate was 
determined in separate multivariate models for patients from low volume versus 
high volume hospitals (data not shown). The results were consistent, and 
furthermore, the models demonstrated crossover effects of survival. One year 
after AAA repair, survival was higher in the very low volume hospitals compared 
to high volume hospitals. This finding suggests that though the sicker, more high-
risk patients who are treated at high volume hospitals may survive the initial 
operation, most likely they are succumbing to pre-existing conditions such as 
heart disease. Alternatively, this finding proposes that differences in outcomes by 
hospital volume are not necessarily attributable to variations in patient 
characteristics or perioperative complication rates. The healthier counterparts who 
are repaired at lower volume hospitals and endure the primary operation have 
improved 1-year survival. These possible explanations of this data are consistent 
with others' findings in that though initial survival rates are higher with EV AR 
compared to open repair, any operative advantage disappears by 1-year following 
the operation. 5•21 
The results presented herein impart several unique contributions to the 
current body of knowledge. These data were obtained from a nationwide 
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database, which is very detailed and prospectively collected by uniformly trained 
personnel. NSQIP includes 123 institutions with undoubtedly more than 123 
surgeons and surgical teams performing elective AAA repairs. Thus, this data set 
is robust with respect to variability in surgical techniques and skills as well as in 
cohort size. Furthermore, NSQIP does not have the patient exclusion criteria that 
randomized trials contain, increasing the generalizability of our results. 
The results of the 2 recent prospective multicenter randomized trials 
demonstrated that when cohorts were matched for comorbid conditions, the 30-
day operative mortality was reduced by treatment by EV AR.9•10 The results 
presented in this manuscript reflect these findings, albeit in an observational 
design, giving more confidence to the superiority ofEV AR in the short-term and 
at one year. However, both of the prospective studies, many retrospective 
reviews, and this study caution practitioners about changes in clinical practice 
until further information on graft durability and failure rates is known. Currently 
available devices have experienced device migration, endoleak, and limb 
thrombosis, resulting in a high rate of secondary procedures and, in rare instances, 
failure to safeguard the patient from aneurysm rupture. Within the NSQIP 
database, reporting of endovascular device failures is not specifically 
documented, thus, the true rate of graft failure cannot be determined. 
Of late, the subject of screening for AAA has come to the forefront for 
policy makers. Similar to colonoscopy and mammography, screening for AAA 
would benefit those individuals who may be at most risk for having an AAA and 
those who may benefit from surgical intervention. Screening ultrasonography for 
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AAA in asymptomatic persons is a highly accurate test, with 95% sensitivity and 
near 100% specificity.34•35 In the 1081h Congress, a bill was introduced on June 21, 
2004 by Greenwood (Rep: Texas). This bill recommends amending title XVIII of 
the Social Security Act to provide coverage of ultrasound screening for AAA 
under Medicare part B. This bill was called the "SCA VE" bill which stands for 
"screen abdominal aortic aneurysms very efficiently" and was supported by the 
National Aneurysm Alliance. 
Controversy has surrounded the issue of population-based AAA screening. 
Advocates state that ultrasound may detect AAAs at a size when rupture is 
unlikely to occur, and therefore, provide an opportunity for early intervention. In 
a 2001 study, over 70,000 men age 65 years and over were recruited to participate 
in a screening program within the United Kingdom (Multicentre Aneurysm 
Screening Study).36 Patients were randomized to receive either screening or 
routine care (no screening) and followed for 4 years. The results found a 53% 
reduction (95% CI 30-64) in those who had screening mainly due to early 
intervention, thus, suggesting beneficial outcomes from a screening program. 
Conversely, a similar trial from Western Australia (n=41 ,000) did not find a 
survival benefit with the exception of selected subpopulations of older men.37 
These data, along with other compelling data from randomized clinical trials 
comparing screened versus nonscreened populations, were considered in policy 
establishrnent.35•38•39 With influence from national organizations including the 
Society of Vascular Surgery and the Society for Vascular Medicine and Biology, 
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the U.S. Preventative Services Task Force published clinical guidelines for AAA 
screening this year.40 These guidelines are listed in Table 5. 
There are several limitations to this study. This review did not have 
aneurysm size data within the databases analyzed. If surgeons began using EV AR 
on healthier patients with small aneurysms, which would not have otherwise been 
repaired, then the results ofEV AR may appear better. With propensity scoring, 
simulating pseudo-randomization randomization, selection bias is decreased, 
although not eliminated. Additionally, use of the BIRLS database, which contains 
veteran death dates regardless whether they occur in a VA facility or elsewhere, 
has been demonstrated to miss approximately 5% to 10% of veteran decedents?9 
However, there is no reason to believe that more EV AR deaths than open deaths 
were overlooked. The use of hospital volume as a surrogate marker for individual 
surgeon caseload or outcomes may not be representative of individual results. No 
current consensus exists on the minimum number of procedures needed to 
maintain or achieve appropriate outcome, however, it is intuitive that higher 
volume centers with more experienced surgeons performing procedures on a 
regular basis will achieve better results. 
The results from this retrospective analysis open several avenues for future 
research endeavors which I plan to explore via potential national/federal funding 
mechanisms. With this pilot data, numerous questions of interest have been raised 
which will be addressed in a larger project grant (VA Investigator Initiated 
Research grant) to be submitted late 2005. My plans include updating the 
database to increase the statistical power and be able to perform subset analyses 
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(age differences, racial disparities, geographical treatment variation, and further 
hospital volume analyses). Additionally, I will explore data collection options to 
gather AAA size data from all of the hospitals participating in the NSQIP 
database as well as information on long-term graft failure or secondary 
interventions. By continuing this area of research and data analysis, I would like 
to contribute to the information practitioners have at hand for both optimum 
patient guidance and treatment decision-making. 
Conclusion 
In this large patient cohort, representing routine clinical practice, 
endovascular repair had superior outcomes to open repair. Patients undergoing 
EV AR had better survival rates and shorter hospital stays than patients having 
open repair. A cautionary note remains regarding long-term graft durability as 
endovascular technology is still in a state of evolution. The institution of widely 
available population-based screening programs may detect asymptomatic 
aneurysms at a smaller size in healthier patients, which are amenable either to 
elective repair or observation. 
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Table 1. Demographics and baseline clinical characteristics of patients 
undergoing elective AAA repair. 
Type of Surgery 
N(%) 
Open EVAR 
Total Patients 1240 (63.4) 717(36.6) 
Demographic factors 70.2 (7.89) 71.6 (7.78) 
Age (mean, (SD) yrs) 
<60 131 (10.6) 50 (7.0) 
60-79 963 (77.6) 562 (78.4) 
::0:80 146 (11.8) 105 (14.6) 
Male gender 1228 (99.0) 714 (99.6) 
Race Non-Hispanic white 995 (80.2) 573 (80.0) 
Black 73 (5.9) 48 (6.7) 
Hispanic 38 (3.1) 17 (2.3) 
Other/unspecified 134 (10.8) 79 (11.0) 
Preoperative factors (NSQIP 
comorbidities) 
ASA classification 
High 328 (26.4) 192 (26.8) 
Moderate 859 (69.3) 503 (70.1) 
Low 53 (4.3) 22 (3.1) 
25 
P value 
NA 
0.0003 
0.0096 
0.1794 
0.7336 
0.4081 
26 
History of COPD 320 (25.8) 191 (26.6) 0.6863 
History ofCHF 32 (2.6) 26 (3.6) 0.1888 
Hepatic insufficiency 41 (3.3) 22(3.1) 0.7737 
Cerebrovascular disease/neuro 320 (25.8) 152 (21.2) 0.0217 
Malignancy 13 (1.1) 8 (1.1) 0.8892 
Diabetes mellitus 
Insulin-dependent 38 (3.1) 33 (4.6) 
NIDDM 126 (10.2) 70 (9.8) 0.2120 
No diabetes 1076 (86.8) 614 
Chronic renal disease 13 (1.1) 8 (1.1) 0.8892 
Smoking history (within last 568 (45.8) 283 (39.5) 0.0064 
year) 
Functional status 
Partially dependent 69 (5.6) 43 (6.0) 
Totally dependent 6 (0.5) 5 (0.7) 0.7644 
Independent 1834 (93.7) 669 (93.3) 
Serum creatinine 2: 2.0 mg/dL 81 (6.5) 36 (5.0) 0.1742 
Preoperative factors 
(PTFand OPC 
co morbidities) 
Angina 114 (9.2) 67 (9.3) 0.9116 
Angina-unstable 41 (3.3) 33 (4.6) 0.1475 
27 
Angina-both 140 (11.3) 89 (12.4) 0.4567 
MI (remote) 669 (54.0) 381 (53.1) 0.7280 
CABG 163 (13.2) 102 (14.2) 0.5008 
PTCA 40 (3.2) 32 (4.5) 0.1613 
Arrhythmia 277 (22.3) 150 (20.9) 0.4642 
Cardiovascular disease 58 (4.7) 24 (3.4) 0.1571 
Ischemic heart disease 47 (3.8) 34 (4.7) 0.3085 
Hypertension 936 (75.5) 532 (74.2) 0.5267 
Hyperlipidemia 661 (53.3) 380 (53.0) 0.8954 
COPD 427 (34.4) 223 (31.1) 0.1314 
CHF 150 (12.1) 103 (14.4) 0.1495 
CRI, ESRD 78 (6.3) 38 (5.3) 0.3713 
Hypertensive renal failure 39 (3.2) 18 (2.5) 0.4211 
Renal Insufficiency 98 (7.9) 57 (8.0) 0.9707 
Cirrhosis 7 (0.6) 12 (1.7) 0.0159 
Stroke history 31 (2.5) 18 (2.5) 0.9886 
Atherosclerotic carotid lesion 29 (2.3) 8 (1.1) 0.0556 
TIA 31 (2.5) 12 (1.7) 0.2296 
CVA 49 (4.0) 22 (3.1) 0.3140 
Carotid lesion 248 (20.0) 113 (15.8) 0.0198 
Low hospital Volume 392 (31.6) 114 (15.9) <0.001 
28 
Definitions: ASA, American Society of Anesthesiology; COPD, chronic 
obstructive pulmonary disease; CHF, congestive heart failure; IDDM, 
insulin dependent diabetes mellitus; MI, myocardial infarction; CABG, 
coronary artery bypass graft; PTCA, percutaneous transluminal coronary 
angioplasty; CRI, chronic renal insufficiency; ESRD, end stage renal 
disease; RF, renal failure; TIA, transient ischemic attack; CV A, 
cerebrovascular accident 
Table 2. Unadjusted outcome rates following open repair and EV AR. 
Type of Surgery 
Mortality and Open EVAR 
Morbidity outcomes, 
n(%) 
30-day mortality 71 (5.7) 22(3.1) 
365-day mortality 149 (12.0) 60 (8.4) 
Any complication1 362 (29.2) 114(15.9) 
Cardiac morbidity 69 (5.6) 14 (1.9) 
Neurological morbidity 10 (0.51) 8 (0.4) 
Pulmonary 158 (8.1) 35 (1.8) 
Renal dysfunction 48 (2.5) 16 (0.8) 
Wound complication 73 (3.7) 28 (1.4) 
Graft failure 7 (0.36) 15 (0.77) 
Postoperative LOS 10.9 ± 14.3 4.6 ± 7.2 
(mean± SD; days) 
ICU stay (mean± SD; 6.3 ± 11.6 2.8 ± 8.6 
days) 
1 Includes all 21 NSQIP postoperative complication variables. 
Definitions: LOS, length of stay; ICU, Intensive care unit. 
P value 
0.0079 
0.0121 
<0.0001 
<0.0001 
0.4952 
<0.0001 
0.0433 
0.0515 
0.002 
<0.0001 
<0.0001 
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Table 3. Adjusted and unadjusted odds ratios following EV AR 
Adjusted Unadjusted 
OR 95%CI p OR 95%CI p 
value value 
30-day 0.58 0.35, 0.97 0.0367 0.52 0.32, 0.85 0.0079 
mortality 
365-day 0.59 0.42, 0.84 0.0028 0.67 0.49, 0.92 0.0121 
mortality 
31 
Table 4. Unadjusted Odds Ratios of Complications Resulting from EV AR 
Compared to Open Repair. 
Odds 95% Confidence P value 
Ratio Interval 
Any complication1 0.46 0.36, 0.58 <0.0001 
Specific Categories 
Cardiac 0.34 0.19, 0.60 0.0001 
Neurological 1.39 0.54, 3.53 0.4898 
Pulmonary 0.35 0.24, 0.51 <0.0001 
Renal dysfunction 0.57 0.43, 2.58 0.8892 
Wound 0.65 0.42, 1.01 0.056 
Graft failure 3.76 1.53, 9.28 0.002 
I Any comphcatwn denotes unadjusted rates, which mclude all 21 NSQIP 
postoperative complication categories. 
Table 5. Summary of recommendations for screening for AAA by the U.S. 
Preventative Services Task Force. 
Rating Recommendation 
B One-time screening for AAA by ultrasonography in men aged 65-75 
who have ever smoked 
32 
c No recommendation for or against screening for AAA in men aged 65-
75 who have never smoked 
D Recommends against routing screening for AAA in women 
33 
Figure La 30-day survival. 
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Figure 2. Propensity score curves for EV AR versus open repair. 
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